Skip to main content
. 2009 Aug;3(4):281–289. doi: 10.5489/cuaj.1121

Table 3.

Survival according to Memorial Sloan-Kettering Cancer Center prognostic subgroup

Group, median survival, mo
MSCKK prognostic subgroup, risk A, IFN-α B + C, TKI HR (95% CI) p value
Favourable 22 NR 0.36 (0.15–0.85) 0.019
Intermediate 11 16 0.60 (0.38–0.96) 0.032
Poor 3 4 0.81 (0.46–1.42) 0.46

CI = confidence interval; HR = hazard ratio; IFN- α = interferon-α; MKSCC = Memorial Sloan-Kettering Caner Center; NR = not reached; TKI = tyrosine kinase inhibitor.